Shares of Rocket Lab Corp. (RKLB) got a nice little boost on Thursday. Why? Because the company just landed its largest contract to date—a cool $190 million for 20 hypersonic test launches. That's the kind of news that tends to make investors sit up and take notice.
This isn't just a one-off deal. It's a four-year arrangement under something called the MACH-TB 2.0 program, which is being led by defense contractor Kratos Defense & Security Solutions Inc. (KTOS). For Rocket Lab, it pushes their total backlog to over 70 launches and, more importantly, more than $2 billion across their launch and space systems businesses. The company says the first mission under this new mega-deal could happen within months, and they're coming in with a perfect track record so far, having completed multiple Mach 5+ flights with a 100% success rate since 2023.
CEO Sir Peter Beck framed the partnership in grand, strategic terms, saying it will "strengthen America's national security" and accelerate hypersonic testing. It's a good reminder that while launching small satellites is cool, the real money in space sometimes has more to do with what's happening back on Earth.
Speaking of business, Rocket Lab is having a busy start to 2026. They've already sold 28 launches in the first quarter, which is nearly as many as they sold in all of 2025. That's the kind of acceleration that gets the attention of both customers and Wall Street.
What the Charts Are Saying
Let's talk about the stock for a minute. From a technical standpoint, things look pretty constructive. Rocket Lab is currently trading just a hair above its 20-day simple moving average and a more comfortable 5.72% above its 100-day average. That generally suggests a bullish short-term trend is in place. The bigger picture is even more impressive: over the past 12 months, the shares have rocketed up 269.97% and are sitting much closer to their 52-week highs than their lows.
The Relative Strength Index (RSI) is at 47.01, which is basically neutral—not overbought, not oversold. Meanwhile, the MACD indicator is showing a bullish crossover. Put it all together, and the technical setup suggests there's room for the stock to keep moving higher. Traders are watching key resistance at $77.50 and key support at $66.50.
The Analyst and Earnings Picture
The company is expected to report its next set of financial results on May 7, 2026. The consensus estimates are looking for improvement: a loss of 8 cents per share, which is better than the prior loss of 12 cents, and revenue of $191.05 million, up significantly from $122.57 million.
The analyst community is largely on board. The stock carries a consensus Buy rating with an average price target of $66.77. Recent moves by analysts have been mostly positive, with firms like Cantor Fitzgerald and Needham maintaining or raising their targets in recent weeks.
The ETF Angle
Here's an interesting piece of the puzzle for Rocket Lab investors: the stock is a major holding in several popular exchange-traded funds (ETFs). This creates a kind of mechanical relationship between the fund and the stock.
- SPDR S&P Aerospace & Defense ETF (XAR): 5.66% Weight
- ARK Autonomous Technology & Robotics ETF (ARKQ): 4.97% Weight
- ARK Space & Defense Innovation ETF (ARKX): 7.81% Weight
Why does this matter? Because Rocket Lab carries such a heavy weight in these funds, any significant money flowing into or out of the ETFs forces automatic buying or selling of the stock by the fund managers. It's a passive effect, but it can have an active impact on the share price.
As of Thursday's premarket trading, Rocket Lab shares were up 1.47% at $70.50. It seems the market likes the sound of a $190 million vote of confidence in hypersonic technology.
